U.S. Psychiatric and Mental Health Congress 2015

Depression is one of the world’s greatest public health problems. As antidepressants are one of the most widely prescribed classes of medications, even modest differences in efficacy or tolerability have important implications. This session will summarize the state-of-the-art antidepressant therapy and touch on areas of controversy. Dr. Thase will also discuss the issues affecting signal detection in antidepressant trials and review each of the major classes of antidepressants, including more newly released drugs and novel therapeutic compounds, such as ketamine and related drugs.